Effects of alum adjuvant or a booster dose on immunogenicity during clinical trials of group B streptococcal type III conjugate vaccines (Q33552269)

28 July 2017

title

Effects of alum adjuvant or a booster dose on immunogenicity during clinical trials of group B streptococcal type III conjugate vaccines (English)

1 reference

28 July 2017

L C Paoletti

1

1 reference

28 July 2017

M A Rench

2

1 reference

28 July 2017

D L Kasper

3

1 reference

28 July 2017

D Molrine

4

1 reference

28 July 2017

D Ambrosino

5

1 reference

28 July 2017

C J Baker

6

1 reference

28 July 2017

language of work or name

English

0 references

publication date

1 November 2001

1 reference

28 July 2017

published in

Infection and Immunity

1 reference

28 July 2017

volume

69

1 reference

28 July 2017

issue

11

1 reference

28 July 2017

page(s)

6696-6701

1 reference

The Common vaccine adjuvant aluminum hydroxide up-regulates accessory properties of human monocytes via an interleukin-4-dependent mechanism

28 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=100045

Antimicrobial susceptibilities of group B streptococci isolated between 1992 and 1996 from patients with bacteremia or meningitis.

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=100045

Immunologic memory induced by a glycoconjugate vaccine in a murine adoptive lymphocyte transfer model.

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=100045

Immune response to type III group B streptococcal polysaccharide-tetanus toxoid conjugate vaccine

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=100045

Adjuvants for human vaccines--current status, problems and future prospects

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=100045

Immunogenicity of group B Streptococcus type III polysaccharide-tetanus toxoid vaccine in baboons.

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=100045

Polysaccharide conjugate vaccine responses in bone marrow transplant patients.

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=100045

Immunization with a Pseudomonas aeruginosa immunotype 5 O polysaccharide-toxin A conjugate vaccine: effect of a booster dose on antibody levels in humans

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=100045

Effect of carrier priming on immunogenicity of saccharide-protein conjugate vaccines

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=100045

Use of capsular polysaccharide-tetanus toxoid conjugate vaccine for type II group B Streptococcus in healthy women

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=100045

Synthesis and preclinical evaluation of glycoconjugate vaccines against group B Streptococcus types VI and VIII.

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=100045

Group B streptococcal disease in the era of intrapartum antibiotic prophylaxis

31 October 2018

1 reference

12 December 2020

Tolerability and immunogenicity of an eleven-valent pneumococcal conjugate vaccine in healthy toddlers

1 reference

12 December 2020

Comparison of prevention strategies for neonatal group B streptococcal infection. A population-based economic analysis

1 reference

12 December 2020

Quantitative determination of antibodies to type III group B streptococcal polysaccharide

1 reference

12 December 2020

Therapeutic potential of human antisera to group B streptococcal glycoconjugate vaccines in neonatal mice

1 reference

12 December 2020

Frequent resistance of clinical group B streptococci isolates to clindamycin and erythromycin

1 reference

12 December 2020

Safety and immunogenicity of capsular polysaccharide-tetanus toxoid conjugate vaccines for group B streptococcal types Ia and Ib

1 reference

12 December 2020

Serotypes VI and VIII predominate among group B streptococci isolated from pregnant Japanese women

1 reference

12 December 2020

10.1128/IAI.69.11.6696-6701.2001

Identifiers

DOI

1 reference

28 July 2017

1 reference

28 July 2017

1 reference